Inhibrx Biosciences(INBX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INBX Inhibrx Biosciences

盘后交易 07-14 16:56:39 EDT

22.96

+1.19

+5.47%

盘后22.96

+0.000.00%

16:04 EDT

最高23.18	最低21.18	成交量16.28万
今开21.77	昨收21.77	日振幅9.15%
总市值3.32亿	流通市值1.77亿	总股本1,448万
成交额367.57万	换手率2.11%	流通股本771.29万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INBX","market":"US","secType":"STK","nameCN":"Inhibrx Biosciences","latestPrice":22.96,"timestamp":1752523200000,"preClose":21.77,"halted":0,"volume":162842,"hourTrading":{"tag":"盘后","latestPrice":22.96,"preClose":22.96,"latestTime":"16:04 EDT","volume":1313,"amount":30146.48,"timestamp":1752523442645},"delay":0,"floatShares":7712893,"shares":14475904,"eps":111.57757,"marketStatus":"盘后交易","change":1.19,"latestTime":"07-14 16:56:39 EDT","open":21.77,"high":23.175,"low":21.1837,"amount":3675729.87554,"amplitude":0.09147,"askPrice":23.75,"askSize":150,"bidPrice":22,"bidSize":2,"shortable":3,"etf":0,"ttmEps":111.57757,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752537600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":21.77,"preHourTrading":{"tag":"盘前","latestPrice":22,"preClose":21.77,"latestTime":"08:06 EDT","volume":20,"amount":440,"timestamp":1752494801887},"postHourTrading":{"tag":"盘后","latestPrice":22.96,"preClose":22.96,"latestTime":"16:04 EDT","volume":1313,"amount":30146.48,"timestamp":1752523442645},"volumeRatio":0.696049,"impliedVol":1.1244,"impliedVolPercentile":0.8601},"requestUrl":"/m/hq/s/INBX","defaultTab":"news","newsList":[{"id":"2551138353","title":"Inhibrx Biosciences, Inc.盘中异动 快速拉升5.14%报22.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551138353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551138353?lang=zh_cn&edition=full","pubTime":"2025-07-15 00:55","pubTimestamp":1752512128,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日00时55分，Inhibrx Biosciences, Inc.股票出现异动，股价大幅拉升5.14%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715005528a44a6846&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715005528a44a6846&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2550396305","title":"Inhibrx Biosciences, Inc.盘中异动 下午盘快速拉升5.27%报22.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550396305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550396305?lang=zh_cn&edition=full","pubTime":"2025-07-12 01:56","pubTimestamp":1752256592,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日01时56分，Inhibrx Biosciences, Inc.股票出现异动，股价急速上涨5.27%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712015632a6a44be1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712015632a6a44be1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2550668205","title":"Inhibrx Biosciences, Inc.盘中异动 临近收盘股价大涨5.02%报20.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550668205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550668205?lang=zh_cn&edition=full","pubTime":"2025-07-10 03:51","pubTimestamp":1752090685,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日03时51分，Inhibrx Biosciences, Inc.股票出现波动，股价快速拉升5.02%。截至发稿，该股报20.94美元/股，成交量21.3176万股，换手率1.47%，振幅6.75%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.55%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710035125a69ff82b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710035125a69ff82b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2549551431","title":"Inhibrx Biosciences, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549551431","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549551431?lang=zh_cn&edition=full","pubTime":"2025-07-08 00:48","pubTimestamp":1751906911,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日00时48分，Inhibrx Biosciences, Inc.股票出现异动，股价大幅拉升5.02%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。其相关个股中，Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为5766.35%、1206.19%、885.11%，振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.，振幅分别为306.72%、233.18%、84.08%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708004831a43c352e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708004831a43c352e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2548886378","title":"Inhibrx Biosciences, Inc.盘中异动 大幅拉升5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548886378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548886378?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:14","pubTimestamp":1751386470,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时14分，Inhibrx Biosciences, Inc.股票出现波动，股价大幅拉升5.33%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.41%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001430a728ca71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001430a728ca71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2542517534","title":"Inhibrx Biosciences, Inc.盘中异动 急速下跌5.18%报13.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542517534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542517534?lang=zh_cn&edition=full","pubTime":"2025-06-12 21:37","pubTimestamp":1749735476,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日21时37分，Inhibrx Biosciences, Inc.股票出现异动，股价急速跳水5.18%。截至发稿，该股报13.92美元/股，成交量1099股，换手率0.01%，振幅1.43%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061221375695198c84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061221375695198c84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2542349417","title":"Inhibrx Biosciences, Inc.盘中异动 股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542349417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542349417?lang=zh_cn&edition=full","pubTime":"2025-06-11 00:29","pubTimestamp":1749572941,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日00时29分，Inhibrx Biosciences, Inc.股票出现波动，股价急速拉升5.28%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Carisma Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大，Nucana Plc、Windtree Therapeutics, Inc.、Evogene Ltd.较为活跃，换手率分别为29232.33%、2763.08%、1320.82%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.、Klotho Neurosciences, Inc.，振幅分别为261.54%、191.40%、108.79%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061100290195168668&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061100290195168668&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2541669438","title":"Inhibrx Biosciences, Inc.盘中异动 急速上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541669438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541669438?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:52","pubTimestamp":1749217931,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时52分，Inhibrx Biosciences, Inc.股票出现异动，股价急速拉升5.16%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Eyenovia, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Tango Therapeutics, Inc.涨幅较大，Nucana Plc、Eyenovia, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为1938.76%、619.74%、80.96%，振幅较大的相关个股有Eyenovia, Inc.、Silo Pharma, Inc.、Tango Therapeutics, Inc.，振幅分别为29.62%、26.33%、21.96%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060621521195116f73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060621521195116f73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2540703848","title":"Inhibrx Biosciences, Inc.盘中异动 快速上涨6.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540703848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540703848?lang=zh_cn&edition=full","pubTime":"2025-06-03 23:20","pubTimestamp":1748964004,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日23时20分，Inhibrx Biosciences, Inc.股票出现异动，股价大幅拉升6.48%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Biomea Fusion, Inc.、Traws Pharma, Inc.、Eyenovia, Inc.涨幅较大，Revelation Biosciences, Inc.、Traws Pharma, Inc.、Nucana Plc较为活跃，换手率分别为3916.91%、1015.80%、914.50%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Biomea Fusion, Inc.、Renovaro Inc.，振幅分别为79.71%、69.03%、57.30%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603232004a6f8d6d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603232004a6f8d6d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2539265738","title":"Inhibrx Biosciences, Inc.盘中异动 急速上涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539265738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539265738?lang=zh_cn&edition=full","pubTime":"2025-05-29 21:39","pubTimestamp":1748525966,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日21时39分，Inhibrx Biosciences, Inc.股票出现波动，股价大幅拉升5.96%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529213926a6f1f219&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529213926a6f1f219&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2537234924","title":"Inhibrx Biosciences, Inc.盘中异动 临近收盘快速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537234924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537234924?lang=zh_cn&edition=full","pubTime":"2025-05-23 04:00","pubTimestamp":1747944032,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日04时00分，Inhibrx Biosciences, Inc.股票出现波动，股价急速下跌5.02%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523040033a6e9431b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523040033a6e9431b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2537232369","title":"Inhibrx Biosciences, Inc.2025财年第一财季实现净利润-43.31百万美元，同比增加44.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537232369","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537232369?lang=zh_cn&edition=full","pubTime":"2025-05-23 00:00","pubTimestamp":1747929643,"startTime":"0","endTime":"0","summary":"5月23日，Inhibrx Biosciences, Inc.公布财报，公告显示公司2025财年第一财季净利润为-43.31百万美元，同比增加44.98%；其中营业收入为0.00美元，每股基本收益为-2.80美元。从资产负债表来看，Inhibrx Biosciences, Inc.总负债1.48亿美元，其中短期债务1.97百万美元，资产负债比为1.65，流动比率为0.06。机构评级：截至2025年5月23日，当前有1家机构对Inhibrx Biosciences, Inc.目标价做出预测，其中目标均价为12.00美元，其中最低目标价为12.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000230a6e914ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000230a6e914ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX"],"gpt_icon":0},{"id":"2537628847","title":"Inhibrx Biosciences, Inc.盘中异动 下午盘大幅上涨5.13%报13.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537628847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537628847?lang=zh_cn&edition=full","pubTime":"2025-05-21 03:12","pubTimestamp":1747768347,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日03时12分，Inhibrx Biosciences, Inc.股票出现异动，股价大幅拉升5.13%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052103122794fcfdd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052103122794fcfdd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2533527589","title":"Inhibrx Biosciences, Inc.盘中异动 下午盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533527589","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533527589?lang=zh_cn&edition=full","pubTime":"2025-05-08 01:51","pubTimestamp":1746640279,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日01时51分，Inhibrx Biosciences, Inc.股票出现异动，股价急速下挫5.14%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508015119a475a4bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508015119a475a4bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2532841067","title":"Inhibrx Biosciences, Inc.盘中异动 下午盘快速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532841067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532841067?lang=zh_cn&edition=full","pubTime":"2025-05-01 02:51","pubTimestamp":1746039102,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日02时51分，Inhibrx Biosciences, Inc.股票出现波动，股价大幅拉升5.12%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.17%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050102514294e94041&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050102514294e94041&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2531757864","title":"Inhibrx Biosciences, Inc.盘中异动 股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531757864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531757864?lang=zh_cn&edition=full","pubTime":"2025-04-29 23:06","pubTimestamp":1745939160,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日23时06分，Inhibrx Biosciences, Inc.股票出现波动，股价快速下跌5.34%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429230600aa2c7e50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429230600aa2c7e50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2529400636","title":"Inhibrx Biosciences, Inc.盘中异动 早盘急速上涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529400636","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529400636?lang=zh_cn&edition=full","pubTime":"2025-04-23 22:25","pubTimestamp":1745418358,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时25分，Inhibrx Biosciences, Inc.股票出现波动，股价大幅拉升5.48%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.43%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423222559a46407c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423222559a46407c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2529551247","title":"Inhibrx Biosciences, Inc.盘中异动 临近收盘大幅拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529551247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529551247?lang=zh_cn&edition=full","pubTime":"2025-04-23 03:57","pubTimestamp":1745351833,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日03时57分，Inhibrx Biosciences, Inc.股票出现异动，股价快速拉升5.01%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为2.28%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423035714aa2c771d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423035714aa2c771d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2517645901","title":"Inhibrx Biosciences, Inc.盘中异动 大幅下跌5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517645901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517645901?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:25","pubTimestamp":1741274709,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时25分，Inhibrx Biosciences, Inc.股票出现异动，股价大幅跳水5.99%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306232509a2629e6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306232509a2629e6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2516677324","title":"Inhibrx Biosciences, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677324?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:37","pubTimestamp":1741099056,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时37分，Inhibrx Biosciences, Inc.股票出现波动，股价急速跳水5.01%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422373696394681&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422373696394681&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inhibrx.com","stockEarnings":[{"period":"1week","weight":0.3331},{"period":"1month","weight":0.483},{"period":"3month","weight":0.8751},{"period":"6month","weight":0.532},{"period":"1year","weight":0.643},{"period":"ytd","weight":0.4136}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inhibrx Biosciences, Inc.于2024年1月8日根据特拉华州法律成立，是Inhibrx, Inc.的直接全资子公司。该公司是一家临床阶段的生物制药公司，拥有一系列新型候选生物治疗药物，使用其专有的模块化蛋白质工程平台开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.100441},{"month":2,"riseRate":0,"avgChangeRate":-0.118883},{"month":3,"riseRate":0.25,"avgChangeRate":-0.108872},{"month":4,"riseRate":0.5,"avgChangeRate":-0.034815},{"month":5,"riseRate":0.25,"avgChangeRate":-0.039218},{"month":6,"riseRate":0.666667,"avgChangeRate":0.088726},{"month":7,"riseRate":0.666667,"avgChangeRate":0.111417},{"month":8,"riseRate":1,"avgChangeRate":0.030836},{"month":9,"riseRate":0.75,"avgChangeRate":0.016607},{"month":10,"riseRate":0.5,"avgChangeRate":0.197255},{"month":11,"riseRate":0.75,"avgChangeRate":0.223807},{"month":12,"riseRate":0.75,"avgChangeRate":0.232405}],"exchange":"NASDAQ","name":"Inhibrx Biosciences","nameEN":"Inhibrx Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inhibrx Biosciences(INBX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inhibrx Biosciences(INBX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inhibrx Biosciences,INBX,Inhibrx Biosciences股票,Inhibrx Biosciences股票老虎,Inhibrx Biosciences股票老虎国际,Inhibrx Biosciences行情,Inhibrx Biosciences股票行情,Inhibrx Biosciences股价,Inhibrx Biosciences股市,Inhibrx Biosciences股票价格,Inhibrx Biosciences股票交易,Inhibrx Biosciences股票购买,Inhibrx Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inhibrx Biosciences(INBX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inhibrx Biosciences(INBX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}